Your browser doesn't support javascript.
loading
Farnesoid X receptor (FXR) agonist ameliorates systemic insulin resistance, dysregulation of lipid metabolism, and alterations of various organs in a type 2 diabetic kidney animal model.
Han, Sang Youb; Song, Hye Kyoung; Cha, Jin Joo; Han, Jee Young; Kang, Young Sun; Cha, Dae Ryong.
Affiliation
  • Han SY; Department of Internal Medicine, Inje University, Ilsan-Paik Hospital, Goyang, Korea.
  • Song HK; Department of Internal Medicine, Korea University, Ansan Hospital, 516 Kojan-Dong, Ansan City, Kyungki-Do, 15355, Korea.
  • Cha JJ; Department of Internal Medicine, Korea University, Ansan Hospital, 516 Kojan-Dong, Ansan City, Kyungki-Do, 15355, Korea.
  • Han JY; Department of Pathology, Inha University, Incheon, Korea.
  • Kang YS; Department of Internal Medicine, Korea University, Ansan Hospital, 516 Kojan-Dong, Ansan City, Kyungki-Do, 15355, Korea.
  • Cha DR; Department of Internal Medicine, Korea University, Ansan Hospital, 516 Kojan-Dong, Ansan City, Kyungki-Do, 15355, Korea. cdragn@unitel.co.kr.
Acta Diabetol ; 58(4): 495-503, 2021 Apr.
Article de En | MEDLINE | ID: mdl-33399988

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Insulinorésistance / Diabète expérimental / Néphropathies diabétiques / Métabolisme lipidique / Isoxazoles Limites: Animals Langue: En Journal: Acta Diabetol Sujet du journal: ENDOCRINOLOGIA Année: 2021 Type de document: Article Pays de publication: Allemagne

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Insulinorésistance / Diabète expérimental / Néphropathies diabétiques / Métabolisme lipidique / Isoxazoles Limites: Animals Langue: En Journal: Acta Diabetol Sujet du journal: ENDOCRINOLOGIA Année: 2021 Type de document: Article Pays de publication: Allemagne